These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29705547)

  • 1. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM; Rutten K
    Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
    Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonism.
    Schiene K; Tzschentke TM; Schröder W; Christoph T
    Eur J Pharmacol; 2015 May; 754():61-5. PubMed ID: 25697471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats.
    Rutten K; De Vry J; Bruckmann W; Tzschentke TM
    Eur J Pharmacol; 2010 Oct; 645(1-3):119-26. PubMed ID: 20674566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.
    Saccone PA; Zelenock KA; Lindsey AM; Sulima A; Rice KC; Prinssen EP; Wichmann J; Woods JH
    J Pharmacol Exp Ther; 2016 Apr; 357(1):17-23. PubMed ID: 26801398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
    Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
    Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.
    Christoph T; Raffa R; De Vry J; Schröder W
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00444. PubMed ID: 30519474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.
    Ces A; Reiss D; Walter O; Wichmann J; Prinssen EP; Kieffer BL; Ouagazzal AM
    Neuropsychopharmacology; 2012 Jan; 37(2):378-89. PubMed ID: 21881568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.
    Schiene K; Schröder W; Linz K; Frosch S; Tzschentke TM; Jansen U; Christoph T
    Eur J Pharmacol; 2018 Aug; 832():90-95. PubMed ID: 29753041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice.
    Khroyan TV; Zaveri NT; Polgar WE; Orduna J; Olsen C; Jiang F; Toll L
    J Pharmacol Exp Ther; 2007 Feb; 320(2):934-43. PubMed ID: 17132815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue.
    Recker MD; Higgins GA
    J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice.
    Khroyan TV; Polgar WE; Orduna J; Montenegro J; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2011 Nov; 339(2):687-93. PubMed ID: 21859931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.
    Podlesnik CA; Ko MC; Winger G; Wichmann J; Prinssen EP; Woods JH
    Psychopharmacology (Berl); 2011 Jan; 213(1):53-60. PubMed ID: 20852848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesia.
    Rutten K; Tzschentke TM; Koch T; Schiene K; Christoph T
    Eur J Pharmacol; 2014 Oct; 741():264-71. PubMed ID: 25169429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.
    Ding H; Kiguchi N; Yasuda D; Daga PR; Polgar WE; Lu JJ; Czoty PW; Kishioka S; Zaveri NT; Ko MC
    Sci Transl Med; 2018 Aug; 10(456):. PubMed ID: 30158150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
    Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
    Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms.
    Goeldner C; Reiss D; Wichmann J; Kieffer BL; Ouagazzal AM
    Neurobiol Learn Mem; 2009 May; 91(4):393-401. PubMed ID: 19100850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.